S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

RIGL Rigel Pharmaceuticals Inc

0.9401

-0.0377 (-3.86%)

Pre Market

Last Updated: 07:17:19

Delayed by 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals Inc News

Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting
Monday 3 June 2024 (46 minutes ago) • PR Newswire (US)

Rigel to Present at the Jefferies Global Healthcare Conference
Thursday 30 May 2024 (4 days ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 29 May 2024 (5 days ago) • Edgar (US Regulatory)

Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
Thursday 23 May 2024 (2 weeks ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 7 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
Tuesday 7 May 2024 (4 weeks ago) • PR Newswire (US)

More Rigel Pharmaceuticals Inc News Articles

Solitario Resources

Audax Renovables

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions